Scleral Lens Use in Neurotrophic Keratopathy: A Review of Current Concepts and Practice.

OBJECTIVE Neurotrophic keratopathy (NK) is a rare corneal condition characterized by epitheliopathy, which is associated with reduced or absent corneal sensation. The main goal of treatment of this condition is the preservation of ocular surface integrity. Contact lenses provide a nonsurgical and reversible option to provide the necessary corneal protection. The purpose of this review was to summarize the available literature regarding the use of contact lenses in the management of NK, with particular emphasis on the use of scleral lenses. METHODS Literature related to both soft and scleral contact lens use as treatment options for NK was reviewed. RESULTS As of yet, randomized clinical trials have compared neither the efficacy of contact lens therapy for NK to other therapeutic alternatives nor outcomes of therapy with different contact lens modalities. However, clinical case reports and limited case series have suggested that scleral lenses may be a safe and effective treatment option for NK at any stage of the disease, preserving epithelial integrity and even improving visual function in patients with this condition. CONCLUSIONS Scleral lenses may be effective in reducing the need for surgical intervention and improving the quality of life in patients with NK.

[1]  R. Gold,et al.  Quantification of Optic Nerve and Sheath Diameter by Transorbital Sonography: A Systematic Review and Metanalysis , 2020, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[2]  Jia Yin,et al.  Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization. , 2019, The ocular surface.

[3]  H. Dua,et al.  Neurotrophic keratopathy , 2018, Progress in Retinal and Eye Research.

[4]  E. Bradley,et al.  Outcomes of Scleral Lens Therapy in Patients with Neurotrophic Keratopathy at a Tertiary Referral Center , 2018 .

[5]  Jennifer S. Harthan,et al.  Therapeutic uses of scleral contact lenses for ocular surface disease: patient selection and special considerations , 2018, Clinical optometry.

[6]  T. Edrington,et al.  Silicone Hydrogel and Rigid Gas-Permeable Scleral Lens Tear Exchange , 2018, Eye & contact lens.

[7]  D. Hodge,et al.  Scleral Lenses in the Management of Corneal Irregularity and Ocular Surface Disease , 2017, Eye & contact lens.

[8]  Clara C. Chan,et al.  EyePrintPRO therapeutic scleral contact lens: indications and outcomes. , 2017, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[9]  D. VanNasdale,et al.  Corneal epithelial bullae after short-term wear of small diameter scleral lenses. , 2017, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[10]  B. Woo Examination Flow for Scleral Lens Fitting , 2017 .

[11]  F. Lemaitre,et al.  Preclinical assessment of scleral lens as a reservoir-based ocular therapeutic system. , 2016, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[12]  Jennifer S. Harthan,et al.  Complications of Scleral Lens Wear , 2016 .

[13]  B. Francis,et al.  Glaucoma surgical considerations for PROSE lens use in patients with ocular surface disease. , 2016, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[14]  Michelle N Lee,et al.  Treatment of Refractory Persistent Corneal Epithelial Defects: A Standardized Approach Using Continuous Wear PROSE Therapy , 2015, Ocular immunology and inflammation.

[15]  M. Schornack Scleral Lenses: A Literature Review , 2015, Eye & contact lens.

[16]  J. González-Méijome,et al.  Modern scleral contact lenses: A review. , 2014, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[17]  Sandeep Jain,et al.  Corneal nerves in health and disease. , 2014, Survey of ophthalmology.

[18]  Aaron B. Zimmerman,et al.  Microbial Keratitis Secondary to Unintended Poor Compliance With Scleral Gas-Permeable Contact Lenses , 2014, Eye & contact lens.

[19]  J. Sutphin,et al.  Deep Anterior Lamellar Keratoplasty for Acanthamoeba Keratitis Complicating the Use of Boston Scleral Lens , 2014, Eye & contact lens.

[20]  Sanjay V. Patel,et al.  Scleral lenses in the management of ocular surface disease. , 2014, Ophthalmology.

[21]  P. Lim,et al.  Treatment of persistent corneal epithelial defect with overnight wear of a prosthetic device for the ocular surface. , 2013, American journal of ophthalmology.

[22]  Savitri Sharma,et al.  Polymicrobial and microsporidial keratitis in a patient using Boston scleral contact lens for Sjogren's syndrome and ocular cicatricial pemphigoid. , 2013, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[23]  Leanne M Nguyen,et al.  Acute red eye (non‐ulcerative keratitis) associated with mini‐scleral contact lens wear for keratoconus , 2013, Clinical and experimental optometry.

[24]  F. Carley,et al.  Scleral contact lens management of bilateral exposure and neurotrophic keratopathy. , 2012, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[25]  D. Brazeau,et al.  Predicting estimates of oxygen transmissibility for scleral lenses. , 2012, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[26]  B. Durbin-Johnson,et al.  Jupiter Scleral Lenses: The UC Davis Eye Center Experience , 2012, Eye & contact lens.

[27]  K. Carrasquillo,et al.  Piggyback Cosmetic Contact Lens as an Occlusion Therapy in a Patient With Familial Dysautonomia , 2010, Eye & contact lens.

[28]  D. Shepard,et al.  Economic appraisal of the Boston Ocular Surface Prosthesis. , 2009, American journal of ophthalmology.

[29]  R. Chuck,et al.  Amyloidosis-Associated Neurotrophic Keratopathy Precipitated by Overcorrected Blepharoptosis , 2009, Cornea.

[30]  D. Jacobs,et al.  The Boston Ocular Surface Prosthesis as a Novel Drug Delivery System for Bevacizumab , 2009, Seminars in ophthalmology.

[31]  D. Jacobs,et al.  Boston Scleral Lens Prosthetic Device for Treatment of Severe Dry Eye in Chronic Graft-Versus-Host Disease , 2007, Cornea.

[32]  S. Reynolds,et al.  Therapeutic options for the management of early neurotrophic keratopathy: a case report and review. , 2006, Optometry.

[33]  David Zadok,et al.  Scleral Contact Lenses May Help Where Other Modalities Fail , 2003, Cornea.

[34]  A. Lambiase,et al.  Neurotrophic keratitis , 2003, Eye.

[35]  D. Tan,et al.  Therapeutic use of Bausch & Lomb PureVision contact lenses. , 2001, The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc.

[36]  J. Erie Current Ocular Therapy , 2000 .

[37]  J. Baum,et al.  Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens. , 2000, American journal of ophthalmology.

[38]  S. Pflugfelder,et al.  Aqueous Tear Production in Patients with Neurotrophic Keratitis , 1996, Cornea.

[39]  E. Cohen,et al.  Microbial keratitis and corneal ulceration associated with therapeutic soft contact lenses. , 1990, The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc.